Practice
Jessica Delbaum is a partner in the firm’s Antitrust Group. Her practice focuses on defending multinational companies’ mergers and acquisitions before the Federal Trade Commission and Department of Justice as well as coordinating the multi-jurisdictional antitrust defense of transactions. Ms. Delbaum also counsels clients on an extensive array of antitrust issues such as competitor collaborations, cartel leniency applications, and Hart-Scott-Rodino Act compliance, including integration planning. Ms. Delbaum has defended substantive merger investigations involving a wide variety of industries, including health care, industrial gases, mining and finance.

Prior to joining Shearman & Sterling, Ms. Delbaum was an Attorney General’s Honors Program Attorney in the Antitrust Division of the Department of Justice. While at the Division, Ms. Delbaum investigated possible violations of the antitrust laws involving mergers and acquisitions, the reporting and waiting requirements of the Hart-Scott-Rodino Act and civil price-fixing.

• Citigroup in its pending sales of EMI’s music publishing division to a consortium led by Sony Corporation and Mubadala Development Company PJSC and EMI’s recorded music division to Vivendi’s Universal Music Group
• NASDAQ OMX in its attempted hostile contested takeover bid for NYSE Euronext
• NASDAQ OMX in its acquisition of FTEN
• EQT/Investor in its sale of CaridianBCT to Terumo Corporation
• Boston Scientific in the sale of its Neurovascular Business to Stryker Corporation
• Anglo American plc in its sale of Moly-Cop and AltaSteel to OneSteel Limited
• Dun & Bradstreet in its acquisition of QED
• Sun Pharmaceutical in its acquisition of Taro Pharmaceutical
• Indústrias Romi SA in its unsolicited offer to purchase Hardinge Inc.
• Cadbury in its acquisition by Kraft Foods
• HeartWare International in its proposed acquisition by Thoratec
• Ciba in its acquisition by BASF AG
• The Depository Trust & Clearing Corporation in its joint venture with Markit (MarkitSERV)
• Merrill Lynch in its acquisition by Bank of America
• Thomson in the sale of NETg to SkillSoft and in the sale of Prometric to Educational Testing Services
• Novartis in the divestiture of its medical nutrition business to Nestlé
• Novartis in its acquisition of Eon Labs
• BOC Group in its acquisition by Linde AG
• Gambro AB in the sale of its U.S. dialysis clinics to DaVita

Publications

• Co-Author, “Strategic Deals Require Strategic Thinking: Antitrust Provisions to Consider in Negotiated Transactions,” M&A Lawyer, February 2010 (with Peter D. Lyons and Beau W. Buffier)